Cisen Pharmaceutical Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002VG4
CNY
18.18
-0.28 (-1.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
3,932.74
4,402.97
4,010.72
3,732.28
3,629.09
4,057.22
3,743.92
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,932.74
4,402.97
4,010.72
3,732.28
3,629.09
4,057.22
3,743.92
Raw Material Cost
1,862.55
1,965.54
1,895.88
1,776.11
1,640.57
1,819.28
1,694.22
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.63
8.46
6.12
7.97
11.49
3.52
5.53
Selling and Distribution Expenses
1,301.58
1,544.42
1,512.50
1,418.83
1,315.29
1,459.87
1,200.08
Other Expenses
28.91
32.49
28.87
28.68
27.72
28.73
30.22
Total Expenditure (Excl Depreciation)
3,460.82
3,843.31
3,703.19
3,489.67
3,244.53
3,569.98
3,202.02
Operating Profit (PBDIT) excl Other Income
471.9
559.7
307.5
242.60000000000002
384.6
487.2
541.9
Other Income
159.59
128.40
85.12
124.71
116.48
101.34
77.45
Operating Profit (PBDIT)
798.30
877.42
607.42
568.65
632.54
728.98
755.84
Interest
7.63
8.46
6.12
7.97
11.49
3.52
5.53
Exceptional Items
10.53
-37.39
-3.12
-6.09
23.03
23.26
-5.67
Gross Profit (PBDT)
2,070.19
2,437.43
2,114.84
1,956.17
1,988.52
2,237.94
2,049.70
Depreciation
224.94
235.84
231.23
222.63
159.98
164.18
177.81
Profit Before Tax
576.26
595.72
366.94
331.97
484.11
584.54
566.83
Tax
60.83
70.43
13.92
2.23
47.16
67.32
64.92
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
508.91
521.34
349.96
334.15
438.78
514.58
503.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
508.91
521.34
349.96
334.15
438.78
514.58
503.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.03
4.09
2.31
-0.24
-1.42
0.21
-0.49
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
514.94
525.43
352.27
333.90
437.36
514.79
503.05
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,949.56
5,727.36
5,332.18
5,054.82
4,800.95
4,572.56
4,176.95
Earnings per share (EPS)
1.12
1.15
0.78
0.74
0.97
1.14
1.11
Diluted Earnings per share
1.12
1.15
0.78
0.74
0.97
1.14
1.11
Operating Profit Margin (Excl OI)
10.52%
11.66%
7.26%
5.93%
9.81%
11.42%
13.37%
Gross Profit Margin
20.37%
18.89%
14.91%
14.86%
17.75%
18.45%
19.89%
PAT Margin
12.94%
11.84%
8.73%
8.95%
12.09%
12.68%
13.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -10.68% vs 9.78% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -2.00% vs 49.13% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -14.73% vs 43.40% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -10.59% vs 39.34% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Cisen Pharmaceutical Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
3,932.74
0
3,932.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,932.74
0
3,932.74
Raw Material Cost
1,862.55
0
1,862.55
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.63
0
7.63
Selling and Distribution Expenses
1,301.58
0
1,301.58
Other Expenses
28.91
0.00
28.91
Total Expenditure (Excl Depreciation)
3,460.82
0
3,460.82
Operating Profit (PBDIT) excl Other Income
471.92
0.00
471.92
Other Income
159.59
0
159.59
Operating Profit (PBDIT)
798.30
0
798.30
Interest
7.63
0
7.63
Exceptional Items
10.53
0
10.53
Gross Profit (PBDT)
2,070.19
0
2,070.19
Depreciation
224.94
0
224.94
Profit Before Tax
576.26
0
576.26
Tax
60.83
0
60.83
Provisions and contingencies
0
0
0.00
Profit After Tax
508.91
0
508.91
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
508.91
0
508.91
Share in Profit of Associates
0
0
0.00
Minority Interest
6.03
0
6.03
Other related items
0.00
0.00
0.00
Consolidated Net Profit
514.94
0
514.94
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,949.56
0
5,949.56
Earnings per share (EPS)
1.12
0
1.12
Diluted Earnings per share
1.12
0
1.12
Operating Profit Margin (Excl OI)
10.52%
0%
0.00
10.52%
Gross Profit Margin
20.37%
0%
0.00
20.37%
PAT Margin
12.94%
0%
0.00
12.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 393.27 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -10.68% vs 9.78% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 51.49 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -2.00% vs 49.13% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 63.87 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -14.73% vs 43.40% in Dec 2023

Annual - Interest
Interest 0.76 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -10.59% vs 39.34% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.52%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023